ADMELOG is a Intravenous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Sanofi-aventis U.s. Llc. The primary component is Insulin Lispro.
Product ID | 0024-5926_38520d41-2f29-4060-b975-e5391fd3774e |
NDC | 0024-5926 |
Product Type | Human Prescription Drug |
Proprietary Name | ADMELOG |
Generic Name | Insulin Lispro |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVENOUS; SUBCUTANEOUS |
Marketing Start Date | 2018-10-19 |
Marketing Category | NDA / NDA |
Application Number | NDA209196 |
Labeler Name | Sanofi-Aventis U.S. LLC |
Substance Name | INSULIN LISPRO |
Active Ingredient Strength | 100 U/mL |
Pharm Classes | Insulin [Chemical/Ingredient],Insulin Analog [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2018-10-19 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA209196 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2018-10-19 |
Ingredient | Strength |
---|---|
INSULIN LISPRO | 100 U/mL |
SPL SET ID: | 0691def8-4a7b-4de3-866f-a280989f47f1 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
PHarm Class EPC | |
NUI Code |
NDC | Brand Name | Generic Name |
---|---|---|
0024-5924 | ADMELOG | ADMELOG |
0024-5926 | ADMELOG | ADMELOG |
0024-5925 | ADMELOG | ADMELOG |
70518-2399 | ADMELOG | ADMELOG |
0002-7510 | Humalog | Insulin lispro |
0002-7511 | Humalog | Insulin lispro |
0002-7512 | Humalog | Insulin lispro |
0002-7516 | Humalog | Insulin lispro |
0002-7712 | Humalog | Insulin lispro |
0002-7714 | Humalog | Insulin lispro |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ADMELOG 87682668 5475626 Live/Registered |
Sanofi 2017-11-13 |
ADMELOG 86787842 5080517 Live/Registered |
Sanofi 2015-10-14 |